CLINICAL_TRIALS
trial_result
· 2019-10-25
Clinical Trial Update: Pharmacokinetics of Lanraplenib in Adults With Impaired Renal Function [Phase 1]
Summary
Phase 1 pharmacokinetics study assessing lanraplenib in adults with impaired renal function; completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Gilead Sciences | Conditions: Inflammatory Disease | Phase 1 | Status: COMPLETED | Results posted: 2019-10-25